Teva Pharmaceutical Industries Press Release

Title Picture
09/18/2018 - 03:22
Teva Announces Early Results of Debt Tender Offer and Election of Early Settlement
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/13/2018 - 20:15
Teva Announces U.S. Approval of AJOVY (TM) (fremanezumab-vfrm) Injection
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/13/2018 - 19:55
Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/11/2018 - 20:52
Teva to Present at the Morgan Stanley Global Healthcare Conference
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/03/2018 - 23:55
Teva Announces $400 Million Debt Tender Offer
Teva Pharmaceutical's picture
Teva Pharmaceutical
08/06/2018 - 06:34
Teva Announces Updated Indication and Vial Presentation for GRANIX (tbo-filgrastim) Injection in United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
07/17/2018 - 20:16
Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report
Teva Pharmaceutical's picture
Teva Pharmaceutical
07/09/2018 - 06:41
Teva Announces Launch of a Generic Version of Uceris in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
06/28/2018 - 19:16
Teva to Present New Fremanezumab Data, Including Long-Term Data, at the American Headache Societys 60th Annual Scientific Meeting
Teva Pharmaceutical's picture
Teva Pharmaceutical
06/15/2018 - 09:49
Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache
Teva Pharmaceutical's picture
Teva Pharmaceutical
05/23/2018 - 04:21
Teva Confirms September PDUFA Date for Fremanezumab
Teva Pharmaceutical's picture
Teva Pharmaceutical
04/26/2018 - 18:40
Teva Presents New Long-Term Data Demonstrating Efficacy and Safety of COPAXONE (glatiramer acetate injection) 40 mg/mL
Teva Pharmaceutical's picture
Teva Pharmaceutical
04/19/2018 - 07:01
Teva and the Procter & Gamble Company Have Agreed to Terminate the PGT Healthcare Partnership
Teva Pharmaceutical's picture
Teva Pharmaceutical
03/26/2018 - 12:01
Teva Announces the Launch of a Generic Version of Lialda in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
03/23/2018 - 13:42
Teva Announces the Launch of a Generic Version of ALOXI in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
03/15/2018 - 13:43
Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals for Infringement of Korlym Patents
Corcept Therapeutics's picture
Corcept Therapeutics
03/12/2018 - 08:36
Teva to Present at the Cowen & Company 38th Annual Healthcare Conference
Teva Pharmaceutical's picture
Teva Pharmaceutical
02/28/2018 - 07:27
Teva Announces Launch of Offering of Senior Notes
Teva Pharmaceutical's picture
Teva Pharmaceutical
02/20/2018 - 02:11
Teva Announces Exclusive Launch of Two Strengths of a Generic Version of Solodyn in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
02/09/2018 - 11:43
Teva Announces Launch of a Generic Version of Syprine in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
02/02/2018 - 09:34
European Medicines Agency (EMA) Accepts Fremanezumab Marketing Authorization Application
Teva Pharmaceutical's picture
Teva Pharmaceutical
02/01/2018 - 07:00
Teva Announces Completion of Global Womens Health Divestiture to CVC Capital Partners
Teva Pharmaceutical's picture
Teva Pharmaceutical
01/08/2018 - 00:44
Teva Announces Global License Agreement with Alder BioPharmaceuticals in the Field of Anti-CGRP-Based Therapy
Teva Pharmaceutical's picture
Teva Pharmaceutical
01/04/2018 - 09:25
Teva to Present at the 36th Annual J.P. Morgan Healthcare Conference
Teva Pharmaceutical's picture
Teva Pharmaceutical
01/02/2018 - 15:20
Teva Announces Launch of an Authorized Generic of Estrace Cream in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
12/27/2017 - 08:06
Teva Announces Exclusive Launch of a Generic Version of Reyataz in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
12/14/2017 - 14:18
Teva Announces Restructuring Plan and Additional Measures to Improve Its Business and Financial Performance
Teva Pharmaceutical's picture
Teva Pharmaceutical
12/13/2017 - 23:46
Teva to Host Conference Call to Discuss Restructuring Plan and Additional Measures to Improve Its Business and Financial Performance at 8:00 a.m. ET on December 14, 2017
Teva Pharmaceutical's picture
Teva Pharmaceutical
12/11/2017 - 12:37
Teva Dismisses Litigation After Mylan Wins U.S. Court Ruling Related to Teva's Cold Filtration Patents for Copaxone 40 mg/mL
Mylan's picture
Mylan
12/11/2017 - 09:18
Teva Announces Exclusive Launch of Generic Viagra Tablets in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
11/29/2017 - 18:56
The New England Journal of Medicine Publishes Data from Pivotal Phase III Trial of Fremanezumab for the Preventive Treatment of Chronic Migraine
Teva Pharmaceutical's picture
Teva Pharmaceutical
11/27/2017 - 12:01
Teva Announces New Organization Structure and Leadership Changes
Teva Pharmaceutical's picture
Teva Pharmaceutical
11/02/2017 - 14:18
Teva Announces Completion of Plan B One-Step Divestiture to Foundation Consumer Healthcare
Teva Pharmaceutical's picture
Teva Pharmaceutical
11/01/2017 - 15:45
Teva Announces Completion of PARAGARD Divestiture to CooperSurgical
Teva Pharmaceutical's picture
Teva Pharmaceutical
10/31/2017 - 14:11
Attorney General Laxalt and 45 States Take New Step in Federal Antitrust Lawsuit Against Generic Drug Makers
Nevada Attorney General's picture
Nevada Attorney...
10/31/2017 - 12:48
Delaware and Other States Expand Price-Fixing Suit Against Pharmaceutical Companies
Delaware State Government's picture
Delaware State ...
10/31/2017 - 07:38
Teva Wins Generic Uceris Patent Trial
Teva Pharmaceutical's picture
Teva Pharmaceutical
10/30/2017 - 14:54
Kare Schultz to Join Teva as President and Chief Executive Officer on November 1, 2017
Teva Pharmaceutical's picture
Teva Pharmaceutical
10/26/2017 - 07:51
Mylan Wins UK Court Ruling Related to Copaxone 40 mg/mL Patent
Mylan's picture
Mylan
10/24/2017 - 04:49
Peregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid Bioservices
Peregrine's picture
Peregrine
10/19/2017 - 09:29
Teva to Highlight New Data in Multiple Sclerosis at Joint ECTRIMS ACTRIMS Congress in Paris
Teva Pharmaceutical's picture
Teva Pharmaceutical
10/17/2017 - 10:09
Teva Announces Submission of Biologics License Application for Fremanezumab to the U.S. FDA
Teva Pharmaceutical's picture
Teva Pharmaceutical
10/12/2017 - 04:02
BioDelivery Sciences Announces Patent Litigation Settlement Agreement with Teva
BioDelivery Sciences International's picture
BioDelivery Sci...
10/05/2017 - 12:39
Mylan, in Partnership with Synthon, Receives Marketing Authorization Approval in Europe for First Generic for Copaxone 40 mg/mL
Mylan's picture
Mylan
10/05/2017 - 08:30
Teva Announces tomys Award Winner at Oncology Satellite Symposium During the 7th International Symposium on Acute Promyelocytic Leukemia (APL) in Rome, Italy
Teva Pharmaceutical's picture
Teva Pharmaceutical
10/04/2017 - 09:44
Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mL
Teva Pharmaceutical's picture
Teva Pharmaceutical
10/03/2017 - 18:55
Mylan Confirms U.S. Launch of First Generic for Copaxone 40 mg/mL 3-Times-a-Week and Generic for Copaxone 20 mg/mL Once-Daily
Mylan's picture
Mylan
10/03/2017 - 16:44
Mylan Announces U.S. FDA Approval of First Generic for Copaxone 40 mg/mL 3-Times-a-Week and May Be Eligible for 180-Day Exclusivity
Mylan's picture
Mylan
09/25/2017 - 12:51
Teva Announces Reintroduction of Generic Depo-Provera in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/19/2017 - 08:46
Teva Completes Amendment to Credit Facilities
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/19/2017 - 07:20
Teva and Nuvelution Pharma Partner to Accelerate Development of AUSTEDO (deutetrabenazine) Tablets for Use in Tourette Syndrome in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/18/2017 - 11:09
New Initiative Creates Scalable Solutions to Improve Care of Patients with Multiple Chronic Conditions
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/18/2017 - 07:49
Teva Announces Sale of Remaining Assets in Specialty Global Womens Health Portfolio for $1.38 Billion
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/14/2017 - 00:17
Teva Continues to Advance Care for Societys Health and Wellbeing
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/11/2017 - 17:49
Teva Announces Sale of PARAGARD (intrauterine copper contraceptive) to CooperSurgical
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/11/2017 - 01:19
Teva Names Kare Schultz as President and Chief Executive Officer
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/06/2017 - 05:50
Teva To Present New Asthma and COPD Data at the 2017 European Respiratory Society (ERS) International Congress
Teva Pharmaceutical's picture
Teva Pharmaceutical
09/05/2017 - 04:11
Teva to Present Fremanezumab Data on Migraine Prevention at the 18th Congress of the International Headache Society
Teva Pharmaceutical's picture
Teva Pharmaceutical
08/30/2017 - 04:01
Teva Announces FDA Approval of AUSTEDO (deutetrabenazine) Tablets for the Treatment of Tardive Dyskinesia in Adults
Teva Pharmaceutical's picture
Teva Pharmaceutical
08/18/2017 - 12:50
Teva Announces Exclusive Launch of Generic Axiron in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical